Furthermore, AKT-independent, PI3K-dependent cancer progression pathways exist [338, 339], meaning that additional drugs targeting multiple nodes upstream of AKT, such as multiple PI3K isoforms and receptor tyrosine kinases, might be required. Here, PIK3CB is linked to cancer.